Publication | Open Access

Synergistic anticancer effects of combined γ-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFκB signaling

Tumor BiologyCelecoxib TreatmentChemoprevention StrategyOncogenic AgentMedicineApoptosisImmunologyPharmacologyCancer Cell BiologyCell DeathAnti-cancer AgentCancer BiologySynergistic Anticancer EffectsCell SignalingCancer Research